Reduced clinical severity during 2022 Shanghai Spring epidemic of SARS-CoV-2 omicron BA.2 variant infection-an integrated account of virus pathogenicity and vaccination effectiveness.

IF 16.3 1区综合性期刊 Q1 MULTIDISCIPLINARY SCIENCES

National Science Review Pub Date : 2024-01-15 eCollection Date: 2024-04-01 DOI:10.1093/nsr/nwae011

Xingyue Wu, Yao Chen, Kangli Cao, Yao Shen, Xueling Wu, Yilin Yang, Zhongshu Kuang, Qingrun Li, Zhenzhen Lu, Yichen Jia, Mian Shao, Guorong Gu, Xiangwei Wang, Ye Yao, Ying Wang, Shaodie Chen, Zhigao Yu, Wei Wei, Longfei Ding, Lulu Lan, Tianwen Gu, Xiangyu Long, Jian Sun, Lingyu Xing, Jiayuan Shen, Yi Han, Yue Luo, Sucheng Mu, Mengna Lin, Xiaoyan Zhang, Rong Zeng, Jianqing Xu, Guoping Zhao, Lihong Huang, Zhenju Song

引用次数: 0

查看原文本刊更多论文

2022 年上海春季流行的 SARS-CoV-2 omicron BA.2 变异感染的临床严重程度降低--病毒致病性和疫苗接种效果的综合说明。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

National Science Review MULTIDISCIPLINARY SCIENCES-

CiteScore

24.10

自引率

1.90%

发文量

249

审稿时长

13 weeks

期刊介绍： National Science Review (NSR; ISSN abbreviation: Natl. Sci. Rev.) is an English-language peer-reviewed multidisciplinary open-access scientific journal published by Oxford University Press under the auspices of the Chinese Academy of Sciences.According to Journal Citation Reports, its 2021 impact factor was 23.178. National Science Review publishes both review articles and perspectives as well as original research in the form of brief communications and research articles.